相关实验视频

Updated: Jan 7, 2026

Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures

Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures

Published on: May 9, 2020

帕金森病中的金氨酸路径失调:疾病调制和治疗的洞察力

Vaibhav A Chakkarwar¹, Yogesh A Kulkarni¹

¹Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed to be University, Mumbai, Maharashtra, India.

International journal of tryptophan research : IJTR

|December 19, 2025

概括

调节 kynurenine 途径 (KP) 为帕金森病 (PD) 提供了一个有前途的治疗策略. 向KP酶可能会抑制神经炎症和神经退行,可能成为新的PD治疗方法和生物标志物.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

帕金森病 (PD) 是一种流行的神经退行性疾病,影响全球数百万人.
神经炎症是由微质激活和炎症媒介驱动的,在PD病变发生过程中起着关键作用.
kynurenine 途径 (KP) 显著调节帕金森症的免疫反应,产生神经毒性和神经保护性化合物.

研究的目的:

为了研究调节帕金森病 (PD) 的 kynurenine 途径 (KP) 的治疗潜力.
探索针对KP酶的药理学药剂的使用,作为PD的新治疗策略.
评估KP代谢物作为PD预测生物标志物的有用性.

主要方法:

对先前关于金氨酸通路 (KP) 在帕金森病 (PD) 中的作用研究的综述.
对研究药物治疗对KP酶的影响进行分析.
检查与KP代谢物相关的神经毒性和神经保护机制.

主要成果:

kynurenine 途径 (KP) 涉及产生神经毒性化合物 (例如,来自微质的酸) 和神经保护性化合物 (例如,来自星球细胞的 kynurenic 酸).
在临床前研究中,KP酶的调节已经显示出预防神经退行症的潜力.
药理上抑制KP酶是一种可行的PD治疗途径.

结论:

准金氨酸通路 (KP) 是帕金森病 (PD) 的新疗法.
KP酶的药理调节剂可以为PD提供一种新的治疗策略.
KP代谢物显示为帕金森病 (PD) 的预测生物标志物具有前景.

关键词:

帕金森病是帕金森氏症的一种疾病.基努瑞尼通路是基努瑞尼的通路.神经退行症的神经退行症神经炎症是一种神经炎症.托芬三聚氨酸是什么

更多相关视频

A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats

A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats

Published on: August 19, 2018

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...

Biosynthesis of Nucleic Acids

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...